Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2333730
Max Phase: Preclinical
Molecular Formula: C22H40O7
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
ID: ALA2333730
Max Phase: Preclinical
Molecular Formula: C22H40O7
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCOCC#CCOC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C22H40O7/c1-2-3-4-5-6-7-8-9-10-11-14-27-15-12-13-16-28-17-18-19(23)20(24)21(25)22(26)29-18/h18-26H,2-11,14-17H2,1H3/t18-,19+,20+,21-,22+/m1/s1
Standard InChI Key: PULCWWJRUSBGHA-CTWRKMMKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.56 | Molecular Weight (Monoisotopic): 416.2774 | AlogP: 1.74 | #Rotatable Bonds: 15 |
Polar Surface Area: 108.61 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.30 | CX Basic pKa: | CX LogP: 3.02 | CX LogD: 3.02 |
Aromatic Rings: 0 | Heavy Atoms: 29 | QED Weighted: 0.24 | Np Likeness Score: 1.01 |
1. Chaveriat L, Gosselin I, Machut C, Martin P.. (2013) Synthesis, surface tension properties and antibacterial activities of amphiphilic D-galactopyranose derivatives., 62 [PMID:23353739] [10.1016/j.ejmech.2012.12.032] |
Source(1):